Found 236 matching trials
A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy Participants PHASE1 The purpose of this study is to measure the effect of ticagrelor on the pha...
Show More Learn More & Join Trial
Study to Assess the Pharmacokinetics of AZD6140 After Single Dose in Healthy Japanese Male Volunteers PHASE1 The purpose of this study is to assess the pharmacokinetics of AZD6140 and ...
Show More Learn More & Join Trial
TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome. PHASE3 Ticagrelor is a potent and fast-acting P2Y12-ADP receptor antagonist recomm...
Show More Learn More & Join Trial
Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4) PHASE4 It is a multi-center randomized clinical trial (RCT) which will enroll 3746...
Show More Location
First Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial
Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke PHASE3 Along with the current clinical trial, the efficacy and safety of 180 mg lo...
Show More Location
Kafr Elsheikh University Hospital
Learn More & Join Trial
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome PHASE2 The purpose of this study is to estimate the risk of bleeding with rivaroxa...
Show More Location
Multiple Locations
Learn More & Join Trial
Low-dose Evaluation of Aspirin After STEMI Patients With PCI: A Multicenter, Double-blind, Randomized Controlled Clinical Trial PHASE4 The study aims to optimize the dual antiplatelet therapy regimen for patien...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease PHASE3 The purpose of this study is to compare the effects of ticagrelor and clopi...
Show More Learn More & Join Trial
COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS PHASE4 Ticagrelor, a new P2Y12 receptor antagonist, achieve faster, consistent and...
Show More Location
Shenyang Northern Hospital
Learn More & Join Trial
The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin PHASE4 Heart attacks are usually caused by clots in a coronary artery, depriving t...
Show More Location
Sheffield Teaching Hospitals NHS Foundation Trust
Learn More & Join Trial